GlassScriptPhysician profile
Rahul Vemula
NPI 1053572024
$23,513.40
in general payments reported to CMS, 2019-2025
30 companies · $2,538 in 2025
The $2,538 reported for 2025 was more than what 87% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $2,340 · 2020: $1,150 · 2021: $3,596 · 2022: $592 · 2023: $9,711 · 2024: $3,587 · 2025: $2,538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,800 · Food and Beverage: $5,814 · Travel and Lodging: $3,010 · Long Term Medical Supply Or Device Loan: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,800.00 |
| Food and Beverage | $5,813.86 |
| Travel and Lodging | $3,010.49 |
| Long Term Medical Supply Or Device Loan | $211.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $9,500.83 | 2019-2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
| Abbvie INC. | $3,155.92 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps, Alloderm |
| Allergan, INC. | $2,038.31 | 2019-2022 | |
| Tela Bio, INC. | $1,992.43 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Stryker Corporation | $1,417.89 | 2021-2023 | Spy-Phi System |
| Musculoskeletal Transplant Foundation INC. | $1,358.25 | 2021-2025 | |
| Davol INC. | $875.65 | 2020-2025 | Phasix Mesh, Bard 3dmax Mesh, Arista Ah Flexitip |
| Kerecis Limited | $558.38 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Revance Therapeutics, INC. | $449.21 | 2024-2025 | Daxxify |
| Axogen | $374.68 | 2021-2025 | |
| Motiva USA, LLC | $359.69 | 2025 | |
| Convatec INC. | $312.96 | 2024-2025 | |
| Integra Lifesciences Corporation | $258.52 | 2024-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $160.85 | 2024 | Restrata Wound Matrix |
| Guard Medical INC. | $115.16 | 2023 | Npseal Medium, Npseal (5), Npseal Large |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $110.52 | 2025 | |
| Innocoll Pharmaceuticals Limited | $97.77 | 2022 | |
| Cashflow Solutions, LLC | $55.39 | 2022-2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Vertex Pharmaceuticals Incorporated | $51.90 | 2025 | |
| Mentor Worldwide LLC | $50.51 | 2022-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Becton, Dickinson and Company | $46.08 | 2024 | Phasix Mesh |
| Dilon Technologies, INC. | $45.43 | 2025 | Hemoblast Bellows |
| W. L. Gore & Associates, INC. | $29.02 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Ascendis Pharma Endocrinology INC | $16.52 | 2025 | Yorvipath |
| Kowa Pharmaceuticals America, INC. | $15.94 | 2023 | Seglentis |
| Galderma Laboratories, L.P. | $14.51 | 2022 | |
| Smith+Nephew, INC. | $13.80 | 2024 | Pico 14 |
| Baxter Healthcare | $13.38 | 2019 | |
| Celgene Corporation | $12.27 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$342.30 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Vemula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.